Conceptio › Archive › ClinicalTrials.gov
ClinicalTrials.govpublic full text

A Study to Evaluate the Safety, Tolerability, and Antitumor Activity of INCB001158 Plus Epacadostat, With or Without Pembrolizumab, in Advanced Solid Tumors

Incyte Corporation · 2018
ClinicalTrials.gov · Datasets · License: Public Domain · 2018
Open Source ↗
melanoma
solid tumors, non-small cell lung cancer (nsclc), melanoma, urothelial carcinoma, squamous cell carcinoma of the head and neck (scchn), small cell lung cancer (sclc), colorectal cancer (crc), arginase 1 inhibitor, indoleamine 2,3-dioxygenase 1 inhibitor, programmed death-1 receptor (pd-1) inhibitor, interventional, phase1
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 837331
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.